Pharma Pricing Experts, Global Pricing Innovation, Announce the Appointment of Mikhael Aktsyzniy to Head Technology and Development

Global Pricing Innovations (GPI) has further strengthened its technology division with the addition of Mikhael Aktsyzniy Mikhael joins GPI from Accenture as Head of Technology and Development to continue GPI’s success providing powerful pharma pricing intelligence based business services to valued clients across Europe and the US. He will be based at the firm’s Global … More Pharma Pricing Experts, Global Pricing Innovation, Announce the Appointment of Mikhael Aktsyzniy to Head Technology and Development

NAVIGATING THE CHALLENGES OF HEALTH TECHNOLOGY ASSESSMENTS

By Pati Ladron, Global Pricing Innovations In the face of restricted budgets, payers worldwide are increasingly using Health Technology Assessments (HTAs) as a way of managing healthcare budgets by providing access to therapies that demonstrate robust clinical and economic effectiveness. HTAs are a systematic method of evaluating new technologies by considering the social, economic, organisational … More NAVIGATING THE CHALLENGES OF HEALTH TECHNOLOGY ASSESSMENTS

GPI are hiring!

GPI are hiring! We are looking for innovative, team-orientated individuals to fill a number of open positions. Pricing Analyst – Data analyst from a pharma/health economics background PMA Consultant – Experienced consultant with solid background in project management and pricing strategies and/or modelling Innovation Lead – Head of Product Innovation where you will have overall responsibility … More GPI are hiring!

International Reference Pricing Reforms

Canada’s plan to revise reference basket In a bid to reduce medicine prices in Canada, the Canadian Minister of Health announced the revision of the reference basket for international reference pricing (IRP). Medicines prices in Canada are regulated by the federal government, through the PMPRB (Patented Medicine Prices Review Board). The current reference rule used … More International Reference Pricing Reforms

Egypt: Drug Price Hikes Highlight Market Volatility

With the largest population in the Middle East and North Africa region, Egypt has attracted a strong presence from multinational pharmaceutical companies. However, current turmoil over drug shortages and drug price hikes underscores the volatility of a market characterised by high out-of-pocket spending. Amid the economic instability that followed the 2011 Arab Spring, President Abdel-Fattah … More Egypt: Drug Price Hikes Highlight Market Volatility

Global Pricing Innovations is pleased to announce the addition of Alan Stewart to the executive team

Global Pricing Innovations (GPI) has strengthened its executive team with the addition of Alan Stewart. Alan joins GPI as Commercial Director to continue GPI’s success providing business services to valued clients across Europe and the US. GPI, the pricing experts, has strengthened its executive team this week with the addition of Alan Stewart. Alan joins … More Global Pricing Innovations is pleased to announce the addition of Alan Stewart to the executive team

AMNOG and the German Reforms: What Will Change?

By Preeti Patel and Sophie Schmitz on Oct 3, 2016  We analyze recent changes in Germany’s pharmaceutical legislation & implications for the industry. Germany is typically prioritized by the pharmaceutical industry: it remains a market with relatively high drug prices, offers extensive commercial opportunities and has an important position as an international reference country to … More AMNOG and the German Reforms: What Will Change?